Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001619856-23-000018
Filing Date
2023-02-23
Accepted
2023-02-23 16:48:11
Documents
1
Period of Report
2023-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167718885507722.html 4  
1 FORM 4 wf-form4_167718885507722.xml 4 4037
  Complete submission text file 0001619856-23-000018.txt   5386
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address
Whiting Nancy (Reporting) CIK: 0001880609 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40631 | Film No.: 23660483